Rank | Gene Set | Z-score |
---|---|---|
1 | melanin biosynthetic process (GO:0042438) | 6.83928369 |
2 | melanin metabolic process (GO:0006582) | 6.41389672 |
3 | secondary metabolite biosynthetic process (GO:0044550) | 5.37786006 |
4 | response to peptidoglycan (GO:0032494) | 5.18421883 |
5 | cellular extravasation (GO:0045123) | 4.26546602 |
6 | detection of molecule of bacterial origin (GO:0032490) | 4.25438153 |
7 | neutrophil activation involved in immune response (GO:0002283) | 4.06321356 |
8 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.99679369 |
9 | positive regulation by symbiont of host defense response (GO:0052509) | 3.97966626 |
10 | modulation by symbiont of host defense response (GO:0052031) | 3.97966626 |
11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.97966626 |
12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.97966626 |
13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.97966626 |
14 | modulation by symbiont of host immune response (GO:0052553) | 3.97966626 |
15 | DNA replication checkpoint (GO:0000076) | 3.91122161 |
16 | glycosphingolipid catabolic process (GO:0046479) | 3.84533847 |
17 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.78104629 |
18 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.72885065 |
19 | pigment cell differentiation (GO:0050931) | 3.69066413 |
20 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.64488428 |
21 | oligosaccharide catabolic process (GO:0009313) | 3.55672501 |
22 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.52581928 |
23 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.52581928 |
24 | melanocyte differentiation (GO:0030318) | 3.49858073 |
25 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.41444552 |
26 | regulation of mast cell degranulation (GO:0043304) | 3.38950899 |
27 | glycolipid catabolic process (GO:0019377) | 3.38459940 |
28 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.35188511 |
29 | GMP metabolic process (GO:0046037) | 3.33068730 |
30 | mitotic metaphase plate congression (GO:0007080) | 3.31796530 |
31 | regulation of spindle organization (GO:0090224) | 3.31405803 |
32 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.30450614 |
33 | macrophage activation (GO:0042116) | 3.30392399 |
34 | granulocyte activation (GO:0036230) | 3.25802296 |
35 | purine nucleobase biosynthetic process (GO:0009113) | 3.23997098 |
36 | positive regulation of mast cell activation (GO:0033005) | 3.22852500 |
37 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.21676627 |
38 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.19094826 |
39 | detection of external biotic stimulus (GO:0098581) | 3.18819355 |
40 | cellular response to arsenic-containing substance (GO:0071243) | 3.16302122 |
41 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 3.16186794 |
42 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.15649009 |
43 | neutrophil mediated immunity (GO:0002446) | 3.15225529 |
44 | macrophage activation involved in immune response (GO:0002281) | 3.13307611 |
45 | germinal center formation (GO:0002467) | 3.12655062 |
46 | response to thyroid hormone (GO:0097066) | 3.11930166 |
47 | positive regulation of chromosome segregation (GO:0051984) | 3.11130513 |
48 | regulation of leukocyte degranulation (GO:0043300) | 3.10928221 |
49 | folic acid metabolic process (GO:0046655) | 3.05179660 |
50 | nucleobase biosynthetic process (GO:0046112) | 3.04092152 |
51 | rhodopsin mediated signaling pathway (GO:0016056) | 3.03543062 |
52 | positive regulation of B cell differentiation (GO:0045579) | 3.02781615 |
53 | protein localization to kinetochore (GO:0034501) | 3.02129462 |
54 | regulation of mast cell activation (GO:0033003) | 3.01956557 |
55 | T-helper 1 type immune response (GO:0042088) | 3.01877443 |
56 | myeloid cell activation involved in immune response (GO:0002275) | 3.00953000 |
57 | mitotic nuclear envelope disassembly (GO:0007077) | 3.00623892 |
58 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.00542911 |
59 | detection of other organism (GO:0098543) | 3.00387826 |
60 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.00140034 |
61 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.99565453 |
62 | positive regulation of leukocyte degranulation (GO:0043302) | 2.99167146 |
63 | protein localization to chromosome, centromeric region (GO:0071459) | 2.98507803 |
64 | neutrophil activation (GO:0042119) | 2.97394194 |
65 | ceramide catabolic process (GO:0046514) | 2.97062500 |
66 | leukocyte aggregation (GO:0070486) | 2.96914589 |
67 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.96742600 |
68 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.95743475 |
69 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.91920408 |
70 | vitamin transmembrane transport (GO:0035461) | 2.91810292 |
71 | detection of biotic stimulus (GO:0009595) | 2.90933007 |
72 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.88789044 |
73 | neutrophil chemotaxis (GO:0030593) | 2.88580734 |
74 | response to protozoan (GO:0001562) | 2.86886209 |
75 | positive thymic T cell selection (GO:0045059) | 2.85296371 |
76 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.84031929 |
77 | iron ion import (GO:0097286) | 2.83533178 |
78 | positive regulation of mast cell degranulation (GO:0043306) | 2.82957312 |
79 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.82957312 |
80 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.82671817 |
81 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.82273895 |
82 | osteoclast differentiation (GO:0030316) | 2.82214881 |
83 | protein localization to endosome (GO:0036010) | 2.81248331 |
84 | response to muramyl dipeptide (GO:0032495) | 2.81052890 |
85 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.80741700 |
86 | neutrophil migration (GO:1990266) | 2.80163705 |
87 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.79094481 |
88 | respiratory burst (GO:0045730) | 2.77709276 |
89 | nuclear envelope disassembly (GO:0051081) | 2.76698044 |
90 | membrane disassembly (GO:0030397) | 2.76698044 |
91 | pre-miRNA processing (GO:0031054) | 2.76537592 |
92 | DNA replication initiation (GO:0006270) | 2.76408860 |
93 | response to laminar fluid shear stress (GO:0034616) | 2.76262686 |
94 | negative regulation of granulocyte differentiation (GO:0030853) | 2.75527604 |
95 | regulation of chemokine biosynthetic process (GO:0045073) | 2.74883680 |
96 | ribosome assembly (GO:0042255) | 2.74789723 |
97 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.74688291 |
98 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.74680143 |
99 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.74374744 |
100 | megakaryocyte development (GO:0035855) | 2.72257096 |
101 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.71950807 |
102 | regulation of histone H3-K27 methylation (GO:0061085) | 2.71832367 |
103 | pinocytosis (GO:0006907) | 2.71424704 |
104 | NIK/NF-kappaB signaling (GO:0038061) | 2.70974638 |
105 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.70273176 |
106 | defense response to protozoan (GO:0042832) | 2.70153162 |
107 | amino sugar catabolic process (GO:0046348) | 2.69071991 |
108 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.68099300 |
109 | microglial cell activation (GO:0001774) | 2.68086319 |
110 | metaphase plate congression (GO:0051310) | 2.67669093 |
111 | regulation of gamma-delta T cell activation (GO:0046643) | 2.67612213 |
112 | adaptation of signaling pathway (GO:0023058) | 2.67306933 |
113 | retinal cone cell development (GO:0046549) | 2.66686709 |
114 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.66574402 |
115 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.64819689 |
116 | N-acetylneuraminate metabolic process (GO:0006054) | 2.63449133 |
117 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.63338267 |
118 | negative regulation of cell killing (GO:0031342) | 2.63338267 |
119 | negative regulation of phagocytosis (GO:0050765) | 2.60712554 |
120 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.60582927 |
121 | regulation of translation in response to stress (GO:0043555) | 2.60557234 |
122 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.59942880 |
123 | regulation of erythrocyte differentiation (GO:0045646) | 2.59860495 |
124 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.59850568 |
125 | mitotic sister chromatid segregation (GO:0000070) | 2.59659831 |
126 | embryonic hemopoiesis (GO:0035162) | 2.59463321 |
127 | myeloid leukocyte mediated immunity (GO:0002444) | 2.58801238 |
128 | negative regulation of interleukin-12 production (GO:0032695) | 2.58441750 |
129 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.57159935 |
130 | erythrocyte maturation (GO:0043249) | 2.56838209 |
131 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.56672142 |
132 | detection of bacterium (GO:0016045) | 2.56273234 |
133 | myeloid dendritic cell differentiation (GO:0043011) | 2.55668187 |
134 | regulation of exit from mitosis (GO:0007096) | 2.55668046 |
135 | negative regulation of histone methylation (GO:0031061) | 2.55443546 |
136 | cellular response to molecule of bacterial origin (GO:0071219) | 2.54957824 |
137 | positive regulation of odontogenesis (GO:0042482) | 2.54894771 |
138 | cellular response to lipopolysaccharide (GO:0071222) | 2.53231151 |
139 | regulation of mononuclear cell migration (GO:0071675) | 2.53085222 |
140 | regulation of RNA export from nucleus (GO:0046831) | 2.53081614 |
141 | myeloid leukocyte activation (GO:0002274) | 2.52616470 |
142 | nuclear envelope organization (GO:0006998) | 2.52459354 |
143 | positive regulation of heat generation (GO:0031652) | 2.51815133 |
144 | DNA strand elongation (GO:0022616) | 2.49955685 |
145 | tolerance induction (GO:0002507) | 2.49700171 |
146 | immunoglobulin mediated immune response (GO:0016064) | 2.48315963 |
147 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.47994739 |
148 | regulation of mitotic spindle organization (GO:0060236) | 2.47936622 |
149 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.45450250 |
150 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.45450250 |
151 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.45450250 |
152 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.44693121 |
153 | ribosome biogenesis (GO:0042254) | 2.44423825 |
154 | response to host (GO:0075136) | 2.43894950 |
155 | response to host defenses (GO:0052200) | 2.43894950 |
156 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.43894950 |
157 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.43040579 |
158 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.41637661 |
159 | regulation of granulocyte differentiation (GO:0030852) | 2.41149700 |
160 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.40753434 |
161 | intestinal epithelial cell development (GO:0060576) | 2.40469930 |
162 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.40125081 |
163 | mannose metabolic process (GO:0006013) | 2.40109977 |
164 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.39327428 |
165 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.38535025 |
166 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.38049858 |
167 | regulation of response to interferon-gamma (GO:0060330) | 2.37624173 |
168 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.37526568 |
169 | telomere maintenance via recombination (GO:0000722) | 2.37180683 |
170 | sister chromatid segregation (GO:0000819) | 2.36161073 |
171 | B cell receptor signaling pathway (GO:0050853) | 2.35511542 |
172 | mitotic chromosome condensation (GO:0007076) | 2.35300583 |
173 | response to host immune response (GO:0052572) | 2.35059339 |
174 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.35059339 |
175 | mitotic sister chromatid cohesion (GO:0007064) | 2.32258775 |
176 | protein localization to chromosome (GO:0034502) | 2.31269068 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.56761479 |
2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.87994809 |
3 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.14970104 |
4 | MYC_22102868_ChIP-Seq_BL_Human | 3.12817950 |
5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.78497617 |
6 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.69904965 |
7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.65005217 |
8 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.55343604 |
9 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.55153900 |
10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.48802671 |
11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.45644802 |
12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.33036266 |
13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.30528121 |
14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.28252410 |
15 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.25508621 |
16 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.17645397 |
17 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.08740413 |
18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.07738427 |
19 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.00005094 |
20 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.99547220 |
21 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.96321636 |
22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.92178223 |
23 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.91643266 |
24 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.91209335 |
25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.88094000 |
26 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.87313248 |
27 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.86008420 |
28 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.84771207 |
29 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.84160926 |
30 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.83347551 |
31 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.76593709 |
32 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.75291019 |
33 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.75010829 |
34 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.70046729 |
35 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69304551 |
36 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.68286378 |
37 | MYB_26560356_Chip-Seq_TH1_Human | 1.67496461 |
38 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.65317706 |
39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.64171249 |
40 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.63993613 |
41 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.63750823 |
42 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.63560229 |
43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.63510839 |
44 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61464516 |
45 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60773803 |
46 | * MYB_26560356_Chip-Seq_TH2_Human | 1.59037382 |
47 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.59003030 |
48 | MAF_26560356_Chip-Seq_TH1_Human | 1.58615376 |
49 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.58381338 |
50 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.57884017 |
51 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.57679318 |
52 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57600640 |
53 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.56470040 |
54 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.56466116 |
55 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.53558906 |
56 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.53510557 |
57 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.52427257 |
58 | GATA1_22025678_ChIP-Seq_K562_Human | 1.51071469 |
59 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.49361481 |
60 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.48881327 |
61 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.48451145 |
62 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.44867950 |
63 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.43847305 |
64 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.42265640 |
65 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.42178228 |
66 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.41396039 |
67 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.41334382 |
68 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41301392 |
69 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.40012333 |
70 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.39682800 |
71 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.39186539 |
72 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.37706093 |
73 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.36538699 |
74 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36150779 |
75 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.35884199 |
76 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.34660650 |
77 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.34511711 |
78 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.33794208 |
79 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.32336710 |
80 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.32027686 |
81 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.30688052 |
82 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.29519334 |
83 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29085636 |
84 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.26956273 |
85 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26620227 |
86 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26393307 |
87 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.25814834 |
88 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25507503 |
89 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.25008757 |
90 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.23338696 |
91 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.23040229 |
92 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.23011346 |
93 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.22314461 |
94 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.21918848 |
95 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19684678 |
96 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.18337656 |
97 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.17754734 |
98 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17420108 |
99 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17095361 |
100 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.16991974 |
101 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.16920636 |
102 | MAF_26560356_Chip-Seq_TH2_Human | 1.15409065 |
103 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.15408295 |
104 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15226767 |
105 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13010697 |
106 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.11849366 |
107 | SPI1_23127762_ChIP-Seq_K562_Human | 1.11626236 |
108 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.10139670 |
109 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.09494434 |
110 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.08312676 |
111 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.08300047 |
112 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.07335891 |
113 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.06956217 |
114 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.06073136 |
115 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.05740844 |
116 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05650697 |
117 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.05364611 |
118 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.04829920 |
119 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.04829920 |
120 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.04745202 |
121 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.04647745 |
122 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.03513443 |
123 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.03400579 |
124 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.03301751 |
125 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.02862805 |
126 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 1.01931941 |
127 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.01433574 |
128 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.01381832 |
129 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.01198333 |
130 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00980329 |
131 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.00836863 |
132 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00773106 |
133 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.98913492 |
134 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.98399282 |
135 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.97828072 |
136 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97573407 |
137 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96895486 |
138 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96706481 |
139 | * ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.96663830 |
140 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.96486182 |
141 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.96412675 |
142 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.95161212 |
143 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.94495251 |
144 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92433898 |
145 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92014566 |
146 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.91839396 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003136_yellow_coat_color | 3.95632390 |
2 | MP0005171_absent_coat_pigmentation | 3.87929311 |
3 | MP0000372_irregular_coat_pigmentation | 3.84233765 |
4 | MP0003693_abnormal_embryo_hatching | 3.49757777 |
5 | MP0008057_abnormal_DNA_replication | 3.42997294 |
6 | MP0002877_abnormal_melanocyte_morpholog | 2.93711654 |
7 | MP0004381_abnormal_hair_follicle | 2.86822896 |
8 | MP0003111_abnormal_nucleus_morphology | 2.83407257 |
9 | MP0000371_diluted_coat_color | 2.77873446 |
10 | MP0002396_abnormal_hematopoietic_system | 2.63056909 |
11 | MP0005408_hypopigmentation | 2.60827814 |
12 | MP0005671_abnormal_response_to | 2.58917085 |
13 | MP0010094_abnormal_chromosome_stability | 2.55720255 |
14 | MP0003656_abnormal_erythrocyte_physiolo | 2.44600751 |
15 | MP0003077_abnormal_cell_cycle | 2.42403887 |
16 | MP0005075_abnormal_melanosome_morpholog | 2.42373394 |
17 | MP0003303_peritoneal_inflammation | 2.41591160 |
18 | MP0003011_delayed_dark_adaptation | 2.35884099 |
19 | MP0001835_abnormal_antigen_presentation | 2.35818779 |
20 | MP0009333_abnormal_splenocyte_physiolog | 2.24735198 |
21 | MP0000569_abnormal_digit_pigmentation | 2.20650410 |
22 | MP0001800_abnormal_humoral_immune | 2.17695955 |
23 | MP0005464_abnormal_platelet_physiology | 2.17621043 |
24 | MP0005257_abnormal_intraocular_pressure | 2.15287970 |
25 | MP0010307_abnormal_tumor_latency | 2.13181169 |
26 | MP0002398_abnormal_bone_marrow | 2.05697592 |
27 | MP0005058_abnormal_lysosome_morphology | 1.98608655 |
28 | MP0001545_abnormal_hematopoietic_system | 1.97350883 |
29 | MP0005397_hematopoietic_system_phenotyp | 1.97350883 |
30 | MP0009840_abnormal_foam_cell | 1.91787982 |
31 | MP0002452_abnormal_antigen_presenting | 1.89969038 |
32 | MP0000689_abnormal_spleen_morphology | 1.86936659 |
33 | MP0005409_darkened_coat_color | 1.86775862 |
34 | MP0008007_abnormal_cellular_replicative | 1.84238363 |
35 | MP0002723_abnormal_immune_serum | 1.83917002 |
36 | MP0004808_abnormal_hematopoietic_stem | 1.83816078 |
37 | MP0002722_abnormal_immune_system | 1.83672287 |
38 | MP0003763_abnormal_thymus_physiology | 1.81701450 |
39 | MP0002420_abnormal_adaptive_immunity | 1.80443910 |
40 | MP0001819_abnormal_immune_cell | 1.79248238 |
41 | MP0006082_CNS_inflammation | 1.78853264 |
42 | MP0004957_abnormal_blastocyst_morpholog | 1.78792081 |
43 | MP0002998_abnormal_bone_remodeling | 1.77333295 |
44 | MP0008058_abnormal_DNA_repair | 1.76629002 |
45 | MP0000343_altered_response_to | 1.74517221 |
46 | MP0000490_abnormal_crypts_of | 1.72413628 |
47 | MP0003436_decreased_susceptibility_to | 1.71256353 |
48 | MP0000716_abnormal_immune_system | 1.69905607 |
49 | MP0002419_abnormal_innate_immunity | 1.68415651 |
50 | MP0005000_abnormal_immune_tolerance | 1.67578855 |
51 | MP0002095_abnormal_skin_pigmentation | 1.67094081 |
52 | MP0003191_abnormal_cellular_cholesterol | 1.64085080 |
53 | MP0003172_abnormal_lysosome_physiology | 1.61483492 |
54 | MP0002405_respiratory_system_inflammati | 1.60987442 |
55 | MP0002429_abnormal_blood_cell | 1.58335134 |
56 | MP0000465_gastrointestinal_hemorrhage | 1.57274213 |
57 | MP0005025_abnormal_response_to | 1.55504272 |
58 | MP0000685_abnormal_immune_system | 1.55390873 |
59 | MP0004264_abnormal_extraembryonic_tissu | 1.55122688 |
60 | MP0005387_immune_system_phenotype | 1.53649014 |
61 | MP0001790_abnormal_immune_system | 1.53649014 |
62 | MP0002075_abnormal_coat/hair_pigmentati | 1.51393489 |
63 | MP0005310_abnormal_salivary_gland | 1.48114798 |
64 | MP0000703_abnormal_thymus_morphology | 1.47956441 |
65 | MP0003300_gastrointestinal_ulcer | 1.47769835 |
66 | MP0001873_stomach_inflammation | 1.45507868 |
67 | MP0005551_abnormal_eye_electrophysiolog | 1.42392115 |
68 | MP0005083_abnormal_biliary_tract | 1.39440465 |
69 | MP0001764_abnormal_homeostasis | 1.38997688 |
70 | MP0005076_abnormal_cell_differentiation | 1.38194862 |
71 | MP0000604_amyloidosis | 1.37799438 |
72 | MP0003075_altered_response_to | 1.37212428 |
73 | MP0000350_abnormal_cell_proliferation | 1.33744433 |
74 | MP0009764_decreased_sensitivity_to | 1.33450502 |
75 | MP0001845_abnormal_inflammatory_respons | 1.33170013 |
76 | MP0001186_pigmentation_phenotype | 1.31427859 |
77 | MP0010155_abnormal_intestine_physiology | 1.30754846 |
78 | MP0003806_abnormal_nucleotide_metabolis | 1.30399756 |
79 | MP0009785_altered_susceptibility_to | 1.30386197 |
80 | MP0009278_abnormal_bone_marrow | 1.28255871 |
81 | MP0005174_abnormal_tail_pigmentation | 1.27614910 |
82 | MP0003453_abnormal_keratinocyte_physiol | 1.25764244 |
83 | MP0003183_abnormal_peptide_metabolism | 1.23799059 |
84 | MP0001324_abnormal_eye_pigmentation | 1.23486192 |
85 | MP0004147_increased_porphyrin_level | 1.21824084 |
86 | MP0004947_skin_inflammation | 1.21499737 |
87 | MP0003690_abnormal_glial_cell | 1.15139127 |
88 | MP0002019_abnormal_tumor_incidence | 1.14637789 |
89 | MP0005451_abnormal_body_composition | 1.13036390 |
90 | MP0005167_abnormal_blood-brain_barrier | 1.12981196 |
91 | MP0001730_embryonic_growth_arrest | 1.12138105 |
92 | MP0002166_altered_tumor_susceptibility | 1.10796739 |
93 | MP0001853_heart_inflammation | 1.10197979 |
94 | MP0003866_abnormal_defecation | 1.09569284 |
95 | MP0005166_decreased_susceptibility_to | 1.06542399 |
96 | MP0005164_abnormal_response_to | 1.06321939 |
97 | MP0006054_spinal_hemorrhage | 1.05774230 |
98 | MP0000313_abnormal_cell_death | 1.01976573 |
99 | MP0008004_abnormal_stomach_pH | 1.00932653 |
100 | MP0008469_abnormal_protein_level | 0.99379232 |
101 | MP0002148_abnormal_hypersensitivity_rea | 0.97424819 |
102 | MP0003828_pulmonary_edema | 0.96100724 |
103 | MP0001851_eye_inflammation | 0.95205896 |
104 | MP0000858_altered_metastatic_potential | 0.94690460 |
105 | MP0000609_abnormal_liver_physiology | 0.91846468 |
106 | MP0000920_abnormal_myelination | 0.91220354 |
107 | MP0002139_abnormal_hepatobiliary_system | 0.90303896 |
108 | MP0002928_abnormal_bile_duct | 0.88486040 |
109 | MP0010352_gastrointestinal_tract_polyps | 0.87788689 |
110 | MP0005380_embryogenesis_phenotype | 0.87476430 |
111 | MP0001672_abnormal_embryogenesis/_devel | 0.87476430 |
112 | MP0002090_abnormal_vision | 0.87026022 |
113 | MP0002086_abnormal_extraembryonic_tissu | 0.86970321 |
114 | MP0003984_embryonic_growth_retardation | 0.86606352 |
115 | MP0005253_abnormal_eye_physiology | 0.85728037 |
116 | MP0003718_maternal_effect | 0.84165475 |
117 | MP0002089_abnormal_postnatal_growth/wei | 0.84103013 |
118 | MP0002088_abnormal_embryonic_growth/wei | 0.83444053 |
119 | MP0003786_premature_aging | 0.83031016 |
120 | MP0003091_abnormal_cell_migration | 0.82990677 |
121 | MP0003221_abnormal_cardiomyocyte_apopto | 0.82545071 |
122 | MP0005248_abnormal_Harderian_gland | 0.81417882 |
123 | MP0001697_abnormal_embryo_size | 0.81285511 |
124 | MP0004233_abnormal_muscle_weight | 0.79718082 |
125 | MP0003448_altered_tumor_morphology | 0.79535777 |
126 | MP0000015_abnormal_ear_pigmentation | 0.78315062 |
127 | MP0002080_prenatal_lethality | 0.77758338 |
128 | MP0004185_abnormal_adipocyte_glucose | 0.77530302 |
129 | MP0002006_tumorigenesis | 0.77449383 |
130 | MP0004883_abnormal_blood_vessel | 0.75972279 |
131 | MP0001666_abnormal_nutrient_absorption | 0.75931653 |
132 | MP0001849_ear_inflammation | 0.74519645 |
133 | MP0005621_abnormal_cell_physiology | 0.73839029 |
134 | MP0001986_abnormal_taste_sensitivity | 0.73620130 |
135 | MP0003795_abnormal_bone_structure | 0.72596726 |
136 | MP0003724_increased_susceptibility_to | 0.72533840 |
137 | MP0008260_abnormal_autophagy | 0.72297322 |
138 | MP0002254_reproductive_system_inflammat | 0.71310125 |
139 | MP0000598_abnormal_liver_morphology | 0.70993689 |
140 | MP0004510_myositis | 0.70825585 |
141 | MP0005197_abnormal_uvea_morphology | 0.70628749 |
142 | MP0001533_abnormal_skeleton_physiology | 0.70546061 |
143 | MP0005377_hearing/vestibular/ear_phenot | 0.68542007 |
144 | MP0003878_abnormal_ear_physiology | 0.68542007 |
145 | MP0010234_abnormal_vibrissa_follicle | 0.67067627 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ocular albinism (HP:0001107) | 5.26202007 |
2 | Congenital stationary night blindness (HP:0007642) | 5.17485265 |
3 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 4.59164136 |
4 | Hypoplasia of the fovea (HP:0007750) | 4.59164136 |
5 | Bony spicule pigmentary retinopathy (HP:0007737) | 4.46109459 |
6 | Iris hypopigmentation (HP:0007730) | 4.35676863 |
7 | Loss of speech (HP:0002371) | 4.28599466 |
8 | Pustule (HP:0200039) | 4.15536829 |
9 | Blue irides (HP:0000635) | 4.04424646 |
10 | Aplasia/Hypoplasia of the macula (HP:0008059) | 4.01717169 |
11 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.86657322 |
12 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.75205632 |
13 | Birth length less than 3rd percentile (HP:0003561) | 3.73994199 |
14 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 3.68615436 |
15 | Recurrent bacterial skin infections (HP:0005406) | 3.67977350 |
16 | Recurrent abscess formation (HP:0002722) | 3.67402219 |
17 | Abnormality of the fovea (HP:0000493) | 3.58708881 |
18 | Pigmentary retinal degeneration (HP:0001146) | 3.47611538 |
19 | Eczematoid dermatitis (HP:0000976) | 3.43148271 |
20 | IgM deficiency (HP:0002850) | 3.40274625 |
21 | Abnormality of the fingertips (HP:0001211) | 3.37640877 |
22 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.33973943 |
23 | White forelock (HP:0002211) | 3.26099337 |
24 | Pendular nystagmus (HP:0012043) | 3.22939509 |
25 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.10978066 |
26 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.10978066 |
27 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.10978066 |
28 | Orchitis (HP:0100796) | 3.09338315 |
29 | Poikilocytosis (HP:0004447) | 3.06051332 |
30 | Recurrent fungal infections (HP:0002841) | 3.04535466 |
31 | Optic neuritis (HP:0100653) | 2.98928586 |
32 | Retrobulbar optic neuritis (HP:0100654) | 2.98928586 |
33 | Recurrent viral infections (HP:0004429) | 2.95021939 |
34 | Mucopolysacchariduria (HP:0008155) | 2.95012939 |
35 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.95012939 |
36 | Petechiae (HP:0000967) | 2.93833825 |
37 | Neurofibrillary tangles (HP:0002185) | 2.93753244 |
38 | Fatigue (HP:0012378) | 2.86918192 |
39 | Myocardial infarction (HP:0001658) | 2.84145849 |
40 | Patchy hypopigmentation of hair (HP:0011365) | 2.80680999 |
41 | Stomatitis (HP:0010280) | 2.75983296 |
42 | Inflammation of the large intestine (HP:0002037) | 2.74486239 |
43 | Disinhibition (HP:0000734) | 2.73718538 |
44 | Abnormal platelet function (HP:0011869) | 2.73314415 |
45 | Impaired platelet aggregation (HP:0003540) | 2.73314415 |
46 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.71820048 |
47 | Colitis (HP:0002583) | 2.69130204 |
48 | Systemic lupus erythematosus (HP:0002725) | 2.67277674 |
49 | Prolonged bleeding time (HP:0003010) | 2.65973838 |
50 | Gastrointestinal inflammation (HP:0004386) | 2.62105194 |
51 | Attenuation of retinal blood vessels (HP:0007843) | 2.61475389 |
52 | Cerebral inclusion bodies (HP:0100314) | 2.60500534 |
53 | Entropion (HP:0000621) | 2.59421352 |
54 | Generalized hypopigmentation of hair (HP:0011358) | 2.57531237 |
55 | Hypopigmentation of the fundus (HP:0007894) | 2.55472127 |
56 | Amyloidosis (HP:0011034) | 2.52182473 |
57 | Vertebral compression fractures (HP:0002953) | 2.47699767 |
58 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.45945760 |
59 | Recurrent skin infections (HP:0001581) | 2.45149139 |
60 | Retinal atrophy (HP:0001105) | 2.44460652 |
61 | Increased cerebral lipofuscin (HP:0011813) | 2.43660440 |
62 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.42097242 |
63 | Generalized hypopigmentation (HP:0007513) | 2.41346543 |
64 | Abnormality of T cell physiology (HP:0011840) | 2.39255275 |
65 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.38514076 |
66 | Achilles tendon contracture (HP:0001771) | 2.38421663 |
67 | Polycythemia (HP:0001901) | 2.36507246 |
68 | Myelodysplasia (HP:0002863) | 2.35717708 |
69 | Neuronal loss in central nervous system (HP:0002529) | 2.35117283 |
70 | Recurrent cutaneous fungal infections (HP:0011370) | 2.34976935 |
71 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.34976935 |
72 | Vacuolated lymphocytes (HP:0001922) | 2.33919558 |
73 | Thrombocytosis (HP:0001894) | 2.32984359 |
74 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.30698879 |
75 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.30698879 |
76 | Abnormality of glycolipid metabolism (HP:0010969) | 2.30698879 |
77 | Lymphopenia (HP:0001888) | 2.29651630 |
78 | Glomerulonephritis (HP:0000099) | 2.28511020 |
79 | Progressive visual loss (HP:0000529) | 2.28398833 |
80 | Chronic otitis media (HP:0000389) | 2.28235021 |
81 | Purpura (HP:0000979) | 2.27198304 |
82 | Freckling (HP:0001480) | 2.25892460 |
83 | Autoimmune thrombocytopenia (HP:0001973) | 2.25283438 |
84 | Obstructive lung disease (HP:0006536) | 2.24402843 |
85 | Chronic obstructive pulmonary disease (HP:0006510) | 2.24402843 |
86 | Photophobia (HP:0000613) | 2.24279617 |
87 | Increased serum ferritin (HP:0003281) | 2.23061273 |
88 | Mediastinal lymphadenopathy (HP:0100721) | 2.22476574 |
89 | Dyschromatopsia (HP:0007641) | 2.21841123 |
90 | Slow saccadic eye movements (HP:0000514) | 2.20979742 |
91 | Epistaxis (HP:0000421) | 2.20629994 |
92 | Urethral obstruction (HP:0000796) | 2.20218926 |
93 | Prominent nose (HP:0000448) | 2.19594786 |
94 | Type II diabetes mellitus (HP:0005978) | 2.18931512 |
95 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.18406326 |
96 | Apathy (HP:0000741) | 2.18027547 |
97 | Granulocytopenia (HP:0001913) | 2.17669385 |
98 | Abnormality of macrophages (HP:0004311) | 2.16669106 |
99 | Acanthocytosis (HP:0001927) | 2.14588305 |
100 | Cellulitis (HP:0100658) | 2.14442135 |
101 | Global brain atrophy (HP:0002283) | 2.13145989 |
102 | Abnormality of the Achilles tendon (HP:0005109) | 2.12880911 |
103 | Hypochromic anemia (HP:0001931) | 2.12697869 |
104 | Meningitis (HP:0001287) | 2.12683598 |
105 | Nuclear cataract (HP:0100018) | 2.12344852 |
106 | Diminished motivation (HP:0000745) | 2.11478206 |
107 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.10867090 |
108 | Pathologic fracture (HP:0002756) | 2.10660211 |
109 | Mutism (HP:0002300) | 2.10374014 |
110 | Abnormality of macular pigmentation (HP:0008002) | 2.09474942 |
111 | Abnormality of T cells (HP:0002843) | 2.08132211 |
112 | Breast hypoplasia (HP:0003187) | 2.07801987 |
113 | Albinism (HP:0001022) | 2.06762010 |
114 | Reticulocytosis (HP:0001923) | 2.06735976 |
115 | Supranuclear gaze palsy (HP:0000605) | 2.05967912 |
116 | Chorioretinal atrophy (HP:0000533) | 2.05636000 |
117 | Dysostosis multiplex (HP:0000943) | 2.05301025 |
118 | Myositis (HP:0100614) | 2.05296687 |
119 | Leukopenia (HP:0001882) | 2.04624898 |
120 | Lymphoma (HP:0002665) | 2.04388749 |
121 | J-shaped sella turcica (HP:0002680) | 2.04339401 |
122 | Interstitial pulmonary disease (HP:0006530) | 2.04274588 |
123 | Cheilitis (HP:0100825) | 2.02691436 |
124 | Bone marrow hypocellularity (HP:0005528) | 2.02594368 |
125 | Subacute progressive viral hepatitis (HP:0006572) | 2.01586177 |
126 | Central scotoma (HP:0000603) | 2.01406828 |
127 | Encephalitis (HP:0002383) | 2.01260168 |
128 | Acute myeloid leukemia (HP:0004808) | 2.00364854 |
129 | Increased IgE level (HP:0003212) | 2.00071301 |
130 | Polyneuropathy (HP:0001271) | 1.98657039 |
131 | Spontaneous hematomas (HP:0007420) | 1.97993201 |
132 | Abnormality of chromosome stability (HP:0003220) | 1.97561171 |
133 | Hematochezia (HP:0002573) | 1.97337478 |
134 | Pulmonary infiltrates (HP:0002113) | 1.96577420 |
135 | Panhypogammaglobulinemia (HP:0003139) | 1.96368464 |
136 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.96191108 |
137 | Vasculitis (HP:0002633) | 1.95814450 |
138 | Progressive neurologic deterioration (HP:0002344) | 1.95430373 |
139 | Chronic diarrhea (HP:0002028) | 1.94575018 |
140 | Abnormality of the periventricular white matter (HP:0002518) | 1.93683216 |
141 | Abnormality of the preputium (HP:0100587) | 1.93231175 |
142 | Gingivitis (HP:0000230) | 1.91896992 |
143 | Abnormality of lateral ventricle (HP:0030047) | 1.91035519 |
144 | Poikiloderma (HP:0001029) | 1.90788376 |
145 | Posterior subcapsular cataract (HP:0007787) | 1.89990111 |
146 | Arterial thrombosis (HP:0004420) | 1.89689679 |
147 | Cone-rod dystrophy (HP:0000548) | 1.89413598 |
148 | T lymphocytopenia (HP:0005403) | 1.89035783 |
149 | Macular degeneration (HP:0000608) | 1.87205665 |
150 | Asymmetric septal hypertrophy (HP:0001670) | 1.86150830 |
151 | Scotoma (HP:0000575) | 1.86143312 |
152 | Upper motor neuron abnormality (HP:0002127) | 1.84542999 |
153 | Premature graying of hair (HP:0002216) | 1.84415908 |
154 | Acute lymphatic leukemia (HP:0006721) | 1.84244429 |
155 | Constricted visual fields (HP:0001133) | 1.84132991 |
156 | Recurrent sinusitis (HP:0011108) | 1.83681761 |
157 | Urticaria (HP:0001025) | 1.81838934 |
158 | Facial hemangioma (HP:0000329) | 1.81775361 |
159 | Personality changes (HP:0000751) | 1.81176527 |
160 | Hepatosplenomegaly (HP:0001433) | 1.80093802 |
161 | B lymphocytopenia (HP:0010976) | 1.79316348 |
162 | Abnormality of B cell number (HP:0010975) | 1.79316348 |
163 | Keratoconjunctivitis sicca (HP:0001097) | 1.79218197 |
164 | Gingival bleeding (HP:0000225) | 1.76545685 |
165 | Axonal loss (HP:0003447) | 1.74413014 |
166 | Hemoptysis (HP:0002105) | 1.74399592 |
167 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.73866073 |
168 | Episodic fever (HP:0001954) | 1.73488122 |
169 | Abnormality of iron homeostasis (HP:0011031) | 1.69304339 |
170 | Chest pain (HP:0100749) | 1.69304330 |
171 | Gastrointestinal infarctions (HP:0005244) | 1.68852874 |
172 | Thoracic kyphosis (HP:0002942) | 1.68599918 |
173 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.68200996 |
174 | Dementia (HP:0000726) | 1.66095415 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PDK2 | 4.17974317 |
2 | MAP4K1 | 3.75915033 |
3 | TAOK3 | 3.25922136 |
4 | NEK2 | 2.90649146 |
5 | MAP3K3 | 2.65953902 |
6 | EEF2K | 2.51278809 |
7 | PRPF4B | 2.44855861 |
8 | TXK | 2.41840923 |
9 | CDK12 | 2.35413528 |
10 | STK16 | 2.29783077 |
11 | MARK3 | 2.25627477 |
12 | IRAK3 | 2.13244668 |
13 | TGFBR2 | 2.10755440 |
14 | BUB1 | 1.93323816 |
15 | BMPR2 | 1.92846526 |
16 | TAOK2 | 1.87752555 |
17 | FGR | 1.84060836 |
18 | STK10 | 1.83677285 |
19 | TYK2 | 1.83268172 |
20 | WEE1 | 1.82968482 |
21 | MATK | 1.82578162 |
22 | MAP3K13 | 1.71961791 |
23 | CDC7 | 1.61900906 |
24 | EIF2AK1 | 1.59934085 |
25 | IRAK4 | 1.57795893 |
26 | ZAP70 | 1.57473968 |
27 | TSSK6 | 1.56489689 |
28 | ICK | 1.54309935 |
29 | VRK1 | 1.48590172 |
30 | PIM1 | 1.39370273 |
31 | RPS6KA4 | 1.38078893 |
32 | MAP3K11 | 1.37265470 |
33 | TAOK1 | 1.37147334 |
34 | TRIB3 | 1.36028004 |
35 | DDR2 | 1.30501036 |
36 | PLK4 | 1.28454488 |
37 | CDK4 | 1.26822769 |
38 | MAP3K1 | 1.25579349 |
39 | GRK1 | 1.23895052 |
40 | MAP3K10 | 1.23580804 |
41 | IRAK2 | 1.23353809 |
42 | JAK3 | 1.22957294 |
43 | TBK1 | 1.22774207 |
44 | MAP2K3 | 1.22699255 |
45 | TTK | 1.21553954 |
46 | GRK6 | 1.20363864 |
47 | MAP3K2 | 1.19088036 |
48 | STK3 | 1.18887687 |
49 | BTK | 1.12888228 |
50 | EIF2AK3 | 1.12028948 |
51 | PDPK1 | 1.11435183 |
52 | BRSK2 | 1.10340329 |
53 | CSF1R | 1.10111629 |
54 | IKBKE | 1.09368389 |
55 | NEK6 | 1.07631733 |
56 | CCNB1 | 1.07572994 |
57 | KIT | 1.06896815 |
58 | SIK3 | 1.06242242 |
59 | BLK | 1.04395103 |
60 | NME2 | 1.02624834 |
61 | RIPK1 | 1.02423231 |
62 | SYK | 1.01717773 |
63 | CHEK2 | 1.01374039 |
64 | DYRK3 | 1.01366220 |
65 | ACVR1B | 0.99708861 |
66 | MAPK11 | 0.96934936 |
67 | PLK1 | 0.96859380 |
68 | RIPK4 | 0.94910293 |
69 | MAPKAPK3 | 0.94432586 |
70 | IKBKB | 0.93176753 |
71 | STK4 | 0.93131196 |
72 | PDK1 | 0.91512916 |
73 | TEC | 0.90537837 |
74 | ERN1 | 0.90302012 |
75 | SIK1 | 0.89401656 |
76 | MOS | 0.89094522 |
77 | ADRBK2 | 0.89024263 |
78 | HCK | 0.87953102 |
79 | SCYL2 | 0.87479610 |
80 | CDK6 | 0.85509122 |
81 | KSR2 | 0.85329933 |
82 | JAK1 | 0.85261651 |
83 | CAMK1D | 0.85241810 |
84 | MAP3K8 | 0.84543923 |
85 | CDC42BPA | 0.84107600 |
86 | SIK2 | 0.83996368 |
87 | FES | 0.83823557 |
88 | JAK2 | 0.83377249 |
89 | RPS6KB2 | 0.82440996 |
90 | LYN | 0.81790132 |
91 | IRAK1 | 0.81309895 |
92 | CDK7 | 0.81015108 |
93 | LATS1 | 0.80476682 |
94 | MAP3K6 | 0.79585215 |
95 | GRK7 | 0.78862986 |
96 | RPS6KA2 | 0.78478435 |
97 | ATR | 0.78421563 |
98 | PKN2 | 0.78145369 |
99 | LCK | 0.77577214 |
100 | ALK | 0.77268733 |
101 | ITK | 0.76555691 |
102 | SRPK1 | 0.74186342 |
103 | TTN | 0.73679215 |
104 | AURKB | 0.73140625 |
105 | CHEK1 | 0.71365899 |
106 | PDGFRB | 0.68670826 |
107 | BRD4 | 0.68473880 |
108 | TYRO3 | 0.68423190 |
109 | MAPK7 | 0.67917715 |
110 | PIM2 | 0.67507310 |
111 | MAPK12 | 0.66299611 |
112 | ABL2 | 0.66235430 |
113 | MKNK2 | 0.65211030 |
114 | CAMK1G | 0.64280709 |
115 | BRSK1 | 0.63506460 |
116 | MAP3K5 | 0.63372150 |
117 | MAP3K14 | 0.62343717 |
118 | PLK3 | 0.62248799 |
119 | MAPK15 | 0.61875254 |
120 | MELK | 0.61282703 |
121 | CSK | 0.60880650 |
122 | TESK2 | 0.60677064 |
123 | CDK9 | 0.60531277 |
124 | RAF1 | 0.59220333 |
125 | PAK4 | 0.59149010 |
126 | PRKAA2 | 0.56952406 |
127 | CHUK | 0.56027684 |
128 | TLK1 | 0.55641563 |
129 | RPS6KL1 | 0.55354670 |
130 | RPS6KC1 | 0.55354670 |
131 | CAMKK2 | 0.55189117 |
132 | PRKAA1 | 0.54665152 |
133 | FGFR3 | 0.54392395 |
134 | YES1 | 0.54287486 |
135 | FGFR4 | 0.53434747 |
136 | CDK2 | 0.53237751 |
137 | STK24 | 0.52924414 |
138 | AKT3 | 0.52498555 |
139 | CLK1 | 0.52475987 |
140 | GSK3A | 0.50150287 |
141 | MAPK4 | 0.49793512 |
142 | CDK8 | 0.48600192 |
143 | NEK9 | 0.48473454 |
144 | PTK6 | 0.47931966 |
145 | PDGFRA | 0.45145094 |
146 | RPS6KA6 | 0.43249303 |
147 | CDK3 | 0.42270627 |
148 | SGK3 | 0.40493924 |
149 | EPHB1 | 0.37738525 |
150 | RPS6KA1 | 0.36406632 |
151 | KSR1 | 0.33975380 |
152 | RPS6KB1 | 0.33629386 |
153 | MAPKAPK2 | 0.33527466 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Phototransduction_Homo sapiens_hsa04744 | 4.25667123 |
2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.75713284 |
3 | DNA replication_Homo sapiens_hsa03030 | 2.60990319 |
4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.23197576 |
5 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.10899843 |
6 | Cell cycle_Homo sapiens_hsa04110 | 1.97813976 |
7 | Mismatch repair_Homo sapiens_hsa03430 | 1.82956575 |
8 | Malaria_Homo sapiens_hsa05144 | 1.79568019 |
9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.79059748 |
10 | RNA transport_Homo sapiens_hsa03013 | 1.76641572 |
11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.75815303 |
12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.73428942 |
13 | Base excision repair_Homo sapiens_hsa03410 | 1.73068672 |
14 | RNA polymerase_Homo sapiens_hsa03020 | 1.72827807 |
15 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.72738486 |
16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.72702052 |
17 | Other glycan degradation_Homo sapiens_hsa00511 | 1.69690214 |
18 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.63559758 |
19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.58686521 |
20 | Leishmaniasis_Homo sapiens_hsa05140 | 1.56991989 |
21 | Bladder cancer_Homo sapiens_hsa05219 | 1.56545036 |
22 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.54749059 |
23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.54659213 |
24 | Phagosome_Homo sapiens_hsa04145 | 1.52550439 |
25 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.46586460 |
26 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.44787487 |
27 | Measles_Homo sapiens_hsa05162 | 1.42407401 |
28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.42395700 |
29 | Salmonella infection_Homo sapiens_hsa05132 | 1.42243288 |
30 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.41969821 |
31 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.38063301 |
32 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.36126924 |
33 | Spliceosome_Homo sapiens_hsa03040 | 1.35201645 |
34 | Homologous recombination_Homo sapiens_hsa03440 | 1.33762182 |
35 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.32520444 |
36 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.31983154 |
37 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.29556769 |
38 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.24889759 |
39 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.24002270 |
40 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.22924303 |
41 | Lysosome_Homo sapiens_hsa04142 | 1.19346821 |
42 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.16927537 |
43 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.16254857 |
44 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.15785428 |
45 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.14249235 |
46 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.14200274 |
47 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.13205936 |
48 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.13079974 |
49 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.13072490 |
50 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.08484517 |
51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.07950046 |
52 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.06224320 |
53 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.05430738 |
54 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.04534280 |
55 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.04466685 |
56 | Apoptosis_Homo sapiens_hsa04210 | 1.04425536 |
57 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.03972115 |
58 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.02990641 |
59 | Influenza A_Homo sapiens_hsa05164 | 1.02741026 |
60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.02693126 |
61 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.01122572 |
62 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.00801592 |
63 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.00277629 |
64 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.99559797 |
65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.99470566 |
66 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98819899 |
67 | Hepatitis B_Homo sapiens_hsa05161 | 0.98484297 |
68 | Viral myocarditis_Homo sapiens_hsa05416 | 0.98238475 |
69 | Asthma_Homo sapiens_hsa05310 | 0.98067009 |
70 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.96988844 |
71 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.93166542 |
72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.93011567 |
73 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.92896319 |
74 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.90673849 |
75 | RNA degradation_Homo sapiens_hsa03018 | 0.90320296 |
76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.90224189 |
77 | Basal transcription factors_Homo sapiens_hsa03022 | 0.90040878 |
78 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.89280046 |
79 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.88377695 |
80 | Endometrial cancer_Homo sapiens_hsa05213 | 0.87305593 |
81 | Tuberculosis_Homo sapiens_hsa05152 | 0.86929380 |
82 | Shigellosis_Homo sapiens_hsa05131 | 0.86734559 |
83 | Amoebiasis_Homo sapiens_hsa05146 | 0.86686871 |
84 | Legionellosis_Homo sapiens_hsa05134 | 0.86314300 |
85 | ABC transporters_Homo sapiens_hsa02010 | 0.85515385 |
86 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.83817462 |
87 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.83415891 |
88 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.83349439 |
89 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.82454209 |
90 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.82438002 |
91 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.82167394 |
92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.81781752 |
93 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77810627 |
94 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.74245288 |
95 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.73906621 |
96 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.73732324 |
97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.73192179 |
98 | Purine metabolism_Homo sapiens_hsa00230 | 0.73056095 |
99 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.72298493 |
100 | Thyroid cancer_Homo sapiens_hsa05216 | 0.71342035 |
101 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.71065618 |
102 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.70918509 |
103 | Prostate cancer_Homo sapiens_hsa05215 | 0.70030860 |
104 | HTLV-I infection_Homo sapiens_hsa05166 | 0.69959981 |
105 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.69127864 |
106 | Prion diseases_Homo sapiens_hsa05020 | 0.69014864 |
107 | Lysine degradation_Homo sapiens_hsa00310 | 0.68994904 |
108 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.65661123 |
109 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.64378225 |
110 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62196224 |
111 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61339533 |
112 | Endocytosis_Homo sapiens_hsa04144 | 0.58253262 |
113 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.58218156 |
114 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.58026816 |
115 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.58022190 |
116 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58008245 |
117 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.57959473 |
118 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.57698260 |
119 | Insulin resistance_Homo sapiens_hsa04931 | 0.57552640 |
120 | Pertussis_Homo sapiens_hsa05133 | 0.57372745 |
121 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.57128772 |
122 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.56348023 |
123 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56120293 |
124 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.56055787 |
125 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.55759903 |
126 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.55514032 |
127 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.54444278 |
128 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.54246492 |
129 | Glioma_Homo sapiens_hsa05214 | 0.53587693 |
130 | Circadian rhythm_Homo sapiens_hsa04710 | 0.52688411 |
131 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.51621102 |
132 | Platelet activation_Homo sapiens_hsa04611 | 0.50453669 |
133 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.49582188 |
134 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48633331 |
135 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.48037495 |
136 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47055744 |
137 | Colorectal cancer_Homo sapiens_hsa05210 | 0.45530441 |
138 | Hepatitis C_Homo sapiens_hsa05160 | 0.44830945 |
139 | Allograft rejection_Homo sapiens_hsa05330 | 0.44425659 |
140 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.43703239 |
141 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.42915607 |
142 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.42491777 |
143 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.41601871 |
144 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.41308721 |
145 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40941591 |
146 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40410875 |
147 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.40243342 |
148 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38353555 |
149 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.38249523 |